The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked investment insights, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • News
  • Stocks
  • Energy
  • Tech
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise
  • Investors Forget About Gold At WORST Possible Time
  • Which Equities Can Best Survive Hyperinflation?
  • U.S. Hyperinflation Unmasked: BoA Sees ‘Transitory Hyper-inflation’ Coming
  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research

Articles

California regulator admits to anxiety as recreational marijuana deadline nears

2017-09-29 THE ASSOCIATED PRESS

In about three months, recreational marijuana sales will kick off in California, yet no one knows exactly how the pot economy will work.

It could take until late November for the state to issue regulations that will govern the new marketplace.

Analysts Are Seeing A Bullish Move for InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF)

2017-09-29

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has seen a strong upward trend over the past few weeks, going from a close of $.27 at the end of August to $.50 currently on the back of strong announcements, and people are taking notice.

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Achieves $43M in Working Capital, Eyes Substantial Production Capacity Increase for 2018

2017-09-29

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, announced on August 29 the achievement of working capital in the amount of $43 million from multiple financings, including strategic partnerships and private placements, during the six months ended June 30, 2017.

Algae Dynamics Corp. (ADYNF) Collaborative Study Yields Possible Breakthrough in Reversing Mental Illness Symptoms Resulting from Adolescent Cannabis Use

2017-09-29

Algae Dynamics Corp. (OTCQB: ADYNF), a company engaged in developing unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils, is making international news through its current collaboration with the University of Western Ontario (now rebranded as Western University).

PotNetwork Holding, Inc. (POTN) Subsidiary Selected as Premier Sponsor of Tommy Chong’s Blazer’s Cup

2017-09-29

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its Diamond CBD subsidiary has been selected as an exclusive premier sponsor of Tommy Chong’s Blazer’s Cup, a large cannabis festival set to take place beginning on December 2, 2017, in San Bernardino, California.

Aurora Cannabis and Namaste Announce Strategic Hardware Supply Agreement

2017-09-28

Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Namaste Technologies Inc. (CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced that the companies have signed an exclusive hardware supply agreement for the Canadian market.

ChineseInvestors.com, Inc. (CIIX) Again Names Paul Dickman as CFO, Pursues Exploding $7.2 Billion Legal Cannabis Market

2017-09-28

ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in an 8K SEC filing that Paul Dickman has returned as its chief financial officer, effective September 25, 2017.

The Green Organic Dutchman Holdings Ltd. Announces Addition to the Board of Directors and Advisory Board

2017-09-28

The Green Organic Dutchman Holdings Ltd. is pleased to announce the addition of Marc Bertrand to the Board of Directors and Jeffrey Scott to the Advisory Board.

Global Payout, Inc. (GOHE) Subsidiary Announces Acquisition of PotSaver

2017-09-27

MoneyTrac Technology, Inc. (“MTRAC”), has finalized a majority ownership acquisition of PotSaver, a revenue-producing community periodical providing listings on discounted cannabis-related products for Southern California dispensaries and shops.

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targets Specific Diseases with its Proprietary Biotechnologies

2017-09-27

Vancouver, Canada-based InMed Pharmaceuticals is a preclinical biotech company that specializes in developing novel drug therapies by manufacturing cannabinoids with the potential to have a therapeutic effect on specific diseases.

Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development

2017-09-27

As the marijuana market continues its widespread growth, researchers remain merely at the threshold of exploring the manifold potential medical applications of cannabis.

Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market

2017-09-27

The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020.

How InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Breakthrough Biosynthesis Works - Video

2017-09-27

There's been a lot of focus lately on InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) breakthrough proprietary biosynthesis technology, and how it could unlock a $6 Billion Industry.

Marapharm Ventures Inc. Announces it has Closed on a Second Cannabis Property in California

2017-09-27

Marapharm Ventures Inc. (CSE: MDM.CN) (FSE: 2M0) (OTCQB: MRPHF) announced today that it has closed escrow and has title and possession of a second cannabis property located in Desert Hot Springs, California for a purchase price of $520,000 USD.

Canopy Health Innovations Provides Operational Update: Provisional Patents Filed and Additional Funding Secured

2017-09-27

Canopy Health Innovations the partly-owned biopharmaceutical research and development subsidiary of Canopy Growth Corporation (TSX: WEED) today announced that it has filed nine provisional patents pertaining to the applications of cannabis and cannabinoid based therapeutics in sleep and related nervous system disorders

  • Previous
  • 1
  • ...
  • 259
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • ...
  • 304
  • Next
Join our Newsletter
 Hand-picked investment insights, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

A New Opportunity in Graphene?

A New Opportunity in Graphene?

2023-07-26
Is Blue Water Petroleum Corp going to be the tech company that finally launches large-scale graphene commercialization?

Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise

Investors Forget About Gold At WORST Possible Time

Which Equities Can Best Survive Hyperinflation?

U.S. Hyperinflation Unmasked: BoA Sees ‘Transitory Hyper-inflation’ Coming

Articles
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2026, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor